Please enable JavaScript to continue using this application.

Compare $CBUS vs $INO | Chartloom

Compare

$CBUS vs $INO

Cibus Inc · Inovio Pharmaceuticals Inc

CBUS

Cibus Inc

INO

Inovio Pharmaceuticals Inc

Compare $CBUS vs $INO

Comparing Cibus Inc and Inovio Pharmaceuticals Inc

CBUSCibus Inc

INOInovio Pharmaceuticals Inc

CBUSCibus Inc

Market cap

$118M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.82x

Rev growth (TTM)

-10.3%

YTD performance

-17.6%

52W performance

5.4%

FCF yield

-39.2%

INOInovio Pharmaceuticals Inc

Market cap

$95M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.48x

Rev growth (TTM)

-100.0%

YTD performance

-32.0%

52W performance

-55.1%

FCF yield

-85.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBUS

INO

Detailed metrics comparison

CBUS

Cibus Inc

INO

Inovio Pharmaceuticals Inc

Market Cap

CBUS$118M

INO$95M

Enterprise Value

CBUS$352M

INO$63M

Price

CBUS$1.55

INO$1.15

P/E Ratio

CBUSN/A

INON/A

P/S Ratio

CBUS27.22x

INO423.69x

EV/Sales

CBUS81.04x

INO312.32x

EV/EBITDA

CBUS0.00x

INO0.00x

P/B Ratio

CBUS8.83x

INO27.44x

P/FCF Ratio

CBUSN/A

INON/A

EV/FCF

CBUS-7.59x

INO-0.78x

PEG Ratio

CBUSN/A

INON/A

Forward P/E (NTM)

CBUSN/A

INON/A

Forward P/S (NTM)

CBUS12.82x

INO2.48x

Revenue (TTM)

CBUS$4M

INO$0

Revenue Growth (YoY)

CBUS-10.3%

INO-100.0%

Forward Rev Growth

CBUS139.3%

INO7491.0%

Gross Margin (TTM)

CBUS100.0%

INO58.9%

Operating Margin (TTM)

CBUS0.0%

INO0.0%

EBITDA Margin (TTM)

CBUS-1124.2%

INO0.0%

Net Margin (TTM)

CBUS-2258.9%

INO0.0%

FCF Margin (TTM)

CBUS-1067.5%

INON/A

Net Income (TTM)

CBUS$-98M

INO$-67M

FCF (TTM)

CBUS$-46M

INO$-81M

EPS (TTM)

CBUS-$1.28

INO-$0.83

ROE (TTM)

CBUS-32060.0%

INO-19050.0%

ROA (TTM)

CBUS-3086.0%

INO-11105.0%

ROIC (TTM)

CBUS-3627.0%

INO-19050.0%

Cash

CBUS$20M

INO$32M

Debt

CBUS$254M

INO$0

Net Cash/Debt

CBUS$-234M

INO$32M

Current Ratio (TTM)

CBUS1.62x

INO1.00x

Quick Ratio (TTM)

CBUS1.47x

INO0.92x

Debt/Equity (TTM)

CBUS17.19x

INO0.00x

Debt/Assets (TTM)

CBUS0.0%

INO0.0%

Interest Coverage (TTM)

CBUSN/A

INON/A

Net Debt/EBITDA (TTM)

CBUS0.00x

INO0.00x

Beta

CBUS1.70

INO1.68

52W Performance

CBUS5.4%

INO-55.1%

YTD Performance

CBUS-17.6%

INO-32.0%

% from 52W High

CBUS-63.0%

INO-57.7%

% from 52W Low

CBUS42.2%

INO104.2%

Asset Turnover (TTM)

CBUS0.01x

INO0.00x

FCF Yield (TTM)

CBUS-39.2%

INO-85.4%

Earnings Yield (TTM)

CBUS-83.0%

INO-71.3%

Dividend Yield (TTM)

CBUSN/A

INON/A

Rule of 40

CBUS-1,077.8

INO-100.0

EV/GP/RG

CBUS0.72

INON/A

Ticker research

View CBUS research View INO research

Metric	CBUS Cibus Inc	INO Inovio Pharmaceuticals Inc
Market & Valuation
Market Cap	$118M	$95M
Enterprise Value	$352M	$63M
Price	$1.55	$1.15
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	423.69x
EV/Sales	81.04x	312.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	27.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	-0.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	2.48x
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	-10.3%	-100.0%
Forward Rev Growth	139.3%	7491.0%
Profitability
Gross Margin (TTM)	100.0%	58.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1124.2%	0.0%
Net Margin (TTM)	-2258.9%	0.0%
FCF Margin (TTM)	-1067.5%	N/A
Net Income (TTM)	$-98M	$-67M
FCF (TTM)	$-46M	$-81M
EPS (TTM)	-$1.28	-$0.83
ROE (TTM)	-32060.0%	-19050.0%
ROA (TTM)	-3086.0%	-11105.0%
ROIC (TTM)	-3627.0%	-19050.0%
Financial Health
Cash	$20M	$32M
Debt	$254M	$0
Net Cash/Debt	$-234M	$32M
Current Ratio (TTM)	1.62x	1.00x
Quick Ratio (TTM)	1.47x	0.92x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	1.68
52W Performance	5.4%	-55.1%
YTD Performance	-17.6%	-32.0%
% from 52W High	-63.0%	-57.7%
% from 52W Low	42.2%	104.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-39.2%	-85.4%
Earnings Yield (TTM)	-83.0%	-71.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	-100.0
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View INO research

Valuation

P/S Ratio

CBUS

27.22x

INO

423.69x

EV/FCF

CBUS

-7.59x

INO

-0.78x

Growth & revenue

Revenue Growth TTM

CBUS

-10.3%

INO

-100.0%

Forward Revenue Growth

INO

7491.0%

CBUS

139.3%

Profitability & performance

Gross Margin

CBUS

100.0%

INO

58.9%

ROE

INO

-19050.0%

CBUS

-32060.0%

FCF Yield %

CBUS

-39.2%

INO

-85.4%

52-Week Performance

CBUS

5.4%

INO

-55.1%

Detailed metrics comparison

CBUS

Cibus Inc

INO

Inovio Pharmaceuticals Inc

Market Cap

CBUS$118M

INO$95M

Enterprise Value

CBUS$352M

INO$63M

Price

CBUS$1.55

INO$1.15

P/E Ratio

CBUSN/A

INON/A

P/S Ratio

CBUS27.22x

INO423.69x

EV/Sales

CBUS81.04x

INO312.32x

EV/EBITDA

CBUS0.00x

INO0.00x

P/B Ratio

CBUS8.83x

INO27.44x

P/FCF Ratio

CBUSN/A

INON/A

EV/FCF

CBUS-7.59x

INO-0.78x

PEG Ratio

CBUSN/A

INON/A

Forward P/E (NTM)

CBUSN/A

INON/A

Forward P/S (NTM)

CBUS12.82x

INO2.48x

Revenue (TTM)

CBUS$4M

INO$0

Revenue Growth (YoY)

CBUS-10.3%

INO-100.0%

Forward Rev Growth

CBUS139.3%

INO7491.0%

Gross Margin (TTM)

CBUS100.0%

INO58.9%

Operating Margin (TTM)

CBUS0.0%

INO0.0%

EBITDA Margin (TTM)

CBUS-1124.2%

INO0.0%

Net Margin (TTM)

CBUS-2258.9%

INO0.0%

FCF Margin (TTM)

CBUS-1067.5%

INON/A

Net Income (TTM)

CBUS$-98M

INO$-67M

FCF (TTM)

CBUS$-46M

INO$-81M

EPS (TTM)

CBUS-$1.28

INO-$0.83

ROE (TTM)

CBUS-32060.0%

INO-19050.0%

ROA (TTM)

CBUS-3086.0%

INO-11105.0%

ROIC (TTM)

CBUS-3627.0%

INO-19050.0%

Cash

CBUS$20M

INO$32M

Debt

CBUS$254M

INO$0

Net Cash/Debt

CBUS$-234M

INO$32M

Current Ratio (TTM)

CBUS1.62x

INO1.00x

Quick Ratio (TTM)

CBUS1.47x

INO0.92x

Debt/Equity (TTM)

CBUS17.19x

INO0.00x

Debt/Assets (TTM)

CBUS0.0%

INO0.0%

Interest Coverage (TTM)

CBUSN/A

INON/A

Net Debt/EBITDA (TTM)

CBUS0.00x

INO0.00x

Beta

CBUS1.70

INO1.68

52W Performance

CBUS5.4%

INO-55.1%

YTD Performance

CBUS-17.6%

INO-32.0%

% from 52W High

CBUS-63.0%

INO-57.7%

% from 52W Low

CBUS42.2%

INO104.2%

Asset Turnover (TTM)

CBUS0.01x

INO0.00x

FCF Yield (TTM)

CBUS-39.2%

INO-85.4%

Earnings Yield (TTM)

CBUS-83.0%

INO-71.3%

Dividend Yield (TTM)

CBUSN/A

INON/A

Rule of 40

CBUS-1,077.8

INO-100.0

EV/GP/RG

CBUS0.72

INON/A

Ticker research

View CBUS research View INO research

Metric	CBUS Cibus Inc	INO Inovio Pharmaceuticals Inc
Market & Valuation
Market Cap	$118M	$95M
Enterprise Value	$352M	$63M
Price	$1.55	$1.15
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	423.69x
EV/Sales	81.04x	312.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	27.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	-0.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	2.48x
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	-10.3%	-100.0%
Forward Rev Growth	139.3%	7491.0%
Profitability
Gross Margin (TTM)	100.0%	58.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1124.2%	0.0%
Net Margin (TTM)	-2258.9%	0.0%
FCF Margin (TTM)	-1067.5%	N/A
Net Income (TTM)	$-98M	$-67M
FCF (TTM)	$-46M	$-81M
EPS (TTM)	-$1.28	-$0.83
ROE (TTM)	-32060.0%	-19050.0%
ROA (TTM)	-3086.0%	-11105.0%
ROIC (TTM)	-3627.0%	-19050.0%
Financial Health
Cash	$20M	$32M
Debt	$254M	$0
Net Cash/Debt	$-234M	$32M
Current Ratio (TTM)	1.62x	1.00x
Quick Ratio (TTM)	1.47x	0.92x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	1.68
52W Performance	5.4%	-55.1%
YTD Performance	-17.6%	-32.0%
% from 52W High	-63.0%	-57.7%
% from 52W Low	42.2%	104.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-39.2%	-85.4%
Earnings Yield (TTM)	-83.0%	-71.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	-100.0
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View INO research